{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:15:55Z","timestamp":1778868955960,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004725","name":"Ministry of Economic Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009480","name":"Stichting Vrienden van het Sophia","doi-asserted-by":"publisher","award":["s17 \\u2010 32"],"award-info":[{"award-number":["s17 \\u2010 32"]}],"id":[{"id":"10.13039\/501100009480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2019.12.016","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T19:32:01Z","timestamp":1578943921000},"page":"337-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Novel GAA Variants and Mosaicism in Pompe Disease Identified by Extended Analyses of Patients with an Incomplete DNA Diagnosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Stijn L.M.","family":"in \u2019t Groen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas O.S.","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna M.P.","family":"van den Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannie","family":"Douben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trijnie","family":"Dijkhuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Witters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-\u00c1ngel","family":"Barba Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"de Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galhana M.","family":"Somers-Bolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper J.","family":"Saris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lies H.","family":"Hoefsloot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atze J.","family":"Bergsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.W.M. Pim","family":"Pijnappel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.12.016_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.a.35662","article-title":"How to describe the clinical spectrum in Pompe disease?","volume":"161A","author":"G\u00fcng\u00f6r","year":"2013","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.omtm.2019.12.016_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"8","author":"Prater","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2019.12.016_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.12.016_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.omtm.2019.12.016_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.12.016_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2019.12.016_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.12.016_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2019.12.016_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22705","article-title":"Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach","volume":"36","author":"Bergsma","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2019.12.016_bib10","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/humu.23854","article-title":"Extension of the Pompe mutation database by linking disease-associated variants to clinical severity","volume":"40","author":"Ni\u00f1o","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2019.12.016_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","article-title":"A genetic modifier of symptom onset in Pompe disease","volume":"43","author":"Bergsma","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtm.2019.12.016_bib12","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1038\/mtna.2016.75","article-title":"From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides","volume":"5","author":"Bergsma","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2019.12.016_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.omtn.2017.03.002","article-title":"GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells","volume":"7","author":"van der Wal","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2019.12.016_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtn.2017.03.001","article-title":"Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease","volume":"7","author":"van der Wal","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2019.12.016_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.ircmb.2017.07.008","article-title":"Alternative Splicing in Genetic Diseases: Improved Diagnosis and Novel Treatment Options","volume":"335","author":"Bergsma","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2019.12.016_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molmed.2014.11.010","article-title":"Mosaicism and uniparental disomy in prenatal diagnosis","volume":"21","author":"Eggermann","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2019.12.016_bib17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41431-019-0348-y","article-title":"Segmental and total uniparental isodisomy (UPiD) as a disease mechanism in autosomal recessive lysosomal disorders: evidence from SNP arrays","volume":"27","author":"Labrijn-Marks","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41431-018-0244-x","article-title":"European guidelines for constitutional cytogenomic analysis","volume":"27","author":"Silva","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160C","author":"Bali","year":"2012","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib20","first-page":"887","article-title":"Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II","volume":"56","author":"Boerkoel","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/nar\/gkt987","article-title":"Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents","volume":"42","author":"Dardis","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2019.12.016_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ng.3021","article-title":"Whole-genome sequence variation, population structure and demographic history of the Dutch population","volume":"46","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-015-0243-x","article-title":"Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease","volume":"3","author":"Schaaf","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2019.12.016_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1399-0004.1998.tb02749.x","article-title":"Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal alpha-glucosidase gene","volume":"53","author":"Kroos","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00508-013-0475-3","article-title":"Effects of immune modulation therapy in the first Croatian infant diagnosed with Pompe disease: a 3-year follow-up study","volume":"126","author":"Markic","year":"2014","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.omtm.2019.12.016_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/gim.2012.136","article-title":"A clinical evaluation tool for SNP arrays, especially for autosomal recessive conditions in offspring of consanguineous parents","volume":"15","author":"Wierenga","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2019.12.016_bib28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1006\/bbrc.1994.2360","article-title":"Deletion of exon 18 is a frequent mutation in glycogen storage disease type II","volume":"203","author":"Van der Kraan","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2019.12.016_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1015621710660","article-title":"Human gene mutation in pathology and evolution","volume":"25","author":"Cooper","year":"2002","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.12.016_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajhg.2019.04.004","article-title":"Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease","volume":"104","author":"Gonorazky","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/302938","article-title":"Phenotypes of patients with \u201csimple\u201d Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics","volume":"66","author":"Dipple","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajmg.c.30270","article-title":"Uniparental disomy and human disease: an overview","volume":"154C","author":"Yamazawa","year":"2010","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmg.2008.058016","article-title":"Complex and segmental uniparental disomy updated","volume":"45","author":"Kotzot","year":"2008","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtm.2019.12.016_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/(SICI)1521-1878(200005)22:5<452::AID-BIES7>3.0.CO;2-K","article-title":"Mechanisms leading to uniparental disomy and their clinical consequences","volume":"22","author":"Robinson","year":"2000","journal-title":"BioEssays"},{"key":"10.1016\/j.omtm.2019.12.016_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cll.2011.08.003","article-title":"Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations","volume":"31","author":"Kearney","year":"2011","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.omtm.2019.12.016_bib37","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.0b013e3182553c11","article-title":"Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy","volume":"78","author":"Ebbink","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2019.12.016_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/dmcn.13740","article-title":"Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain","volume":"60","author":"Ebbink","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.omtm.2019.12.016_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.nmd.2010.11.016","article-title":"A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers","volume":"21","author":"van den Berg","year":"2011","journal-title":"Neuromuscul. Disord."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:53:26Z","timestamp":1778867606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":39,"alternative-id":["S2329050120300073"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.016","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel GAA Variants and Mosaicism in Pompe Disease Identified by Extended Analyses of Patients with an Incomplete DNA Diagnosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}